Genscript Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SHSC:1548 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
04 Oct 24	SellHK$474,680	Li Zhu	Individual	35,000	HK$13.56
02 Oct 24	SellHK$901,250	Li Zhu	Individual	64,375	HK$14.00
11 Apr 24	SellHK$1,002,523	Zhenyu Liu	Individual	79,695	HK$12.58
11 Apr 24	SellHK$190,227	Weihui Shao	Individual	15,122	HK$12.58
22 Mar 24	SellHK$407,916	Li Zhu	Individual	28,094	HK$14.52
19 Mar 24	SellHK$455,414	Li Zhu	Individual	28,869	HK$15.78
02 Jan 24	SellHK$610,447	Jiange Meng	Individual	31,867	HK$19.16

Insider Trading Volume

Insider Buying: 1548 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1548?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	4,232,413	0.197%
Institutions	375,114,303	17.5%
Private Companies	800,637,123	37.4%
General Public	963,086,144	44.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 52.34% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
37.3%	GenScript Corporation	799,999,123	HK$7.8b	0%	no data
2.39%	The Vanguard Group, Inc.	51,162,730	HK$498.3m	0.37%	no data
1.76%	BlackRock, Inc.	37,648,228	HK$366.7m	1.69%	no data
1.66%	HuaAn Fund Management Company Ltd.	35,544,000	HK$346.2m	0%	0.18%
1.51%	GF Fund Management Co., Ltd.	32,336,000	HK$315.0m	0%	0.08%
1.03%	Bosera Asset Management Co., Ltd.	22,064,000	HK$214.9m	0%	0.12%
1.02%	Zhong Ou Fund Management Co., Ltd	21,808,068	HK$212.4m	0%	0.1%
0.97%	Harvest Fund Management Co. Ltd.	20,872,000	HK$203.3m	0%	0.06%
0.56%	AEGON-Industrial Fund Management Co. Ltd.	12,054,000	HK$117.4m	0%	0.08%
0.51%	Penghua Fund Management Co., Ltd.	10,842,000	HK$105.6m	0%	0.08%
0.42%	China Asset Management Co. Ltd.	8,985,393	HK$87.5m	-0.06%	0.01%
0.4%	Hillhouse Investment Management, Ltd.	8,578,000	HK$83.6m	0%	0.1%
0.33%	Huatai-PineBridge Fund Management Co., Ltd.	7,086,590	HK$69.0m	0%	0.02%
0.3%	Bank of China Investment Management Co., Ltd.	6,364,000	HK$62.0m	0%	0.18%
0.28%	Bank of Communications Schroder Fund Management Co., Ltd.	6,081,484	HK$59.2m	0%	0.06%
0.27%	Caisse de dépôt et placement du Québec	5,785,814	HK$56.4m	0%	0.01%
0.25%	China Southern Asset Management Co., Ltd.	5,454,000	HK$53.1m	0%	0.02%
0.25%	Geode Capital Management, LLC	5,334,014	HK$52.0m	1.23%	no data
0.25%	Tianhong Asset Management Co., Ltd.	5,260,000	HK$51.2m	0%	0.03%
0.18%	UBS Asset Management AG	3,779,106	HK$36.8m	41.2%	no data
0.16%	E Fund Management Co., Ltd.	3,470,000	HK$33.8m	0%	no data
0.15%	Fullgoal Fund Management Co. Ltd.	3,110,000	HK$30.3m	0%	0.01%
0.14%	Huashang Fund Management Company Ltd.	2,901,659	HK$28.3m	0%	0.05%
0.12%	Charles Schwab Investment Management, Inc.	2,615,105	HK$25.5m	0%	no data
0.12%	China Merchants Fund Management Company Ltd.	2,606,000	HK$25.4m	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 20:42
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genscript Biotech Corporation is covered by 21 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Linda Lu	BOCI Research Ltd.
Jin Zhang	China International Capital Corporation Limited
Yue-Kwong Lui	China Renaissance Securities